You ask the questions - we develop the answers.

We combine professional management with scientific expertise.

The Institute for Pharmacology and Preventive Medicine

The Institute is an experienced partner of universities, non-university institutions, health insurance companies, and pharmaceutical companies in the implementation of scientific projects in the fields of cardiovascular disease and diabetes.

Icon Beratung

Consulting

We offer the trustworthy advice of a medical doctor and a pharmacist.

read more

Icon Klinische Register

Clinical Registries

Clinical registries across Europe are our primary area of expertise.

read more

Icon Prüfzentrum

Validation Centre

We will test and validate your blood pressure monitors.

read more

IPPMed Partnership

Prof. Dr. Peter Bramlage (physician) and Dr. Johannes Hankowitz (pharmacist) work closely together in the Institute for Pharmacology and Preventive Medicine, Dr. Bramlage & Dr. Hankowitz Partnership. Dr Bramlage focuses on collaboration with partners from industry and universities on scientific questions and the evaluation and publication of study data. Dr Hankowitz is experienced in the preparation and assessment of drug evaluations within the AMNOG (Pharmaceuticals Market Reorganisation Act) and editor of AMNOG-monitor.

IPPMed GmbH

Our activities in the areas of clinical registries and validation of blood pressure monitoring devices are a part of IPPMed – Institute for Pharmacology and Preventive Medicine GmbH. This is managed by Prof. Dr. Peter Bramlage and Beate Beime. Here, together with the highly experienced staff at our office in Cloppenburg, we regularly carry out large scale projects involving the latest pharmaceuticals and medical devices.
The close collaboration with clients, as well as with external investigators, ensures the high quality of our work. We focus primarily on cardiovascular indications, hypertension, thrombosis, and diabetes.

Scientist / Physician wanted!
Medical Writer wanted!


To enhance our scientific output we are looking for an experienced scientist with cardiovascular disease experience as well as a (native English) Medical Writer.

Recent Activity / Publications in press


Nielsen NE, Baranowska J, Bramlage P, Baranowski J. Minimising the risk for left ventricular rupture during transcatheter aortic valve implantation by reducing stiff guidewires presence in the ventricle. ICVTS 2019.

Schellong SM, Riess H, Spannagl M, Omran H, Schwarzbach M, Langer F, Gogarten W, Bramlage P, Bauersachs RM. [Bridging anticoagulation in patients receiving Vitamin K antagonists: Current status]. Gefässchirurg 2019.


Bramlage P, Lanzinger S, van Mark G, Hess E, Fahrner S, Heyer CHJ, Friebe M, Seufert J, Danne T, Holl RW. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease – an analysis of the German DPV and DIVE databases. Cardiovascular Diabetology 2019.

Butter C, Okamoto M, Schymik G, Jacobshagen C, Rothe J, Treede H, Kerber S, Frank D, Bramlage P, Sykorova L, Thoenes M, Rudolph TK. Degree of valve calcification in patients undergoing transfemoral TAVI with and without balloon aortic valvuloplasty – findings from the multicenter EASE-IT TF registry. Catheterization and Cardiovascular Interventions 2019.

van Mark G, Lanzinger S, Barion R, Degenhardt M, Badis S, Noll H, Danne T, Bramlage P, Seufert J, Holl RW. Patient and disease characteristics of adult patients with type 1 diabetes in Germany – an analysis of the DPV and DIVE databases. Therapeutic Advances in Endocrinology and Metabolism 2019.

Barbanti M, van Mourik MS, Spence MS, Iacovelli F, Martinelli GL, Muir DF, Saia F, Bortone AS, Densem CG, van der Kley F, Bramlage P, Vis M, Tamburino C. Collaborators: Baan J, Kurucova J, Thoenes M, Lüske CM, Deutsch C, Costa G, Owens CG. Optimizing Patient Discharge Management after Transfemoral Transcatheter Aortic Valve Implantation: The Multicentre European FAST-TAVI Trial. EuroIntervention 2019.

Wernio E, Malgorzewicz S, Dardzinska JA, Jagielak D, Rogowski J, Gruszecka A, Klapowski A, Bramlage P. Association between nutritional status and mortality after aortic valve replacement procedure in elderly with severe aortic stenosis. Nutrients 2019.

Kofler M, Reinstadtler SJ, Mayr A, Stastny L, Reindl M, Dumfarth J, Dachs TM, Wachter K, Rustenbach CJ, Friedrich G, Feuchtner G, Klug G, Metzler B, Gimme M, Baumbach H, Bramlage P, Bonaros N. Prognostic Implications of Psoas Muscle Area in Patients Undergoing Transcatheter Aortic Valve Implantation. EJCTS 2019.

Gatzke N, Güc N, Hillmeister P, Dülsner A, LeNoble F, Buschmann EE, Ingwersen M, Bramlage P, Buschmann IR. Cardiovascular drugs attenuated myocardial resistance against ischemia- and reperfusion-induced injury in a rat model of repetitive occlusion. Open Heart 2018.

Gellert G, Bramlage P. Use of the ClearSight System for continuous non-invasive hemodynamic monitoring during heart valve interventions: review of the literature and single-site experience. The Heart Surgery Forum 2018.

Veröffentlichungen mit PubMed Listung

Our Partners


logo S4TRAILS
Logo da-cro
Logo DK ONE TECH
Logo IHF
logo Beate Beime Pharma Consulting